Detalles de la búsqueda
1.
Long-term follow-up of coronary venous bypass graft lesions treated with a new generation drug-eluting stent with bioabsorbable polymer.
J Interv Cardiol
; 26(5): 425-33, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23962106
2.
Comparison of cardiogoniometry and electrocardiography with perfusion cardiac magnetic resonance imaging and late gadolinium enhancement.
Europace
; 14(12): 1793-8, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22791298
3.
Initial experience with an institutional bridging protocol for patients with recent coronary stent implantation requiring discontinuation of dual antiplatelet therapy resulting from urgent surgery.
Am J Ther
; 18(6): e280-2, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20634687
4.
Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis.
Eur Heart J
; 29(16): 1975-82, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18550554
5.
Inducible cardiac-restricted expression of enteroviral protease 2A is sufficient to induce dilated cardiomyopathy.
Circulation
; 115(1): 94-102, 2007 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-17190866
6.
Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
N Engl J Med
; 353(7): 663-70, 2005 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-16105990
7.
Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss.
Circulation
; 113(2): 273-9, 2006 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-16391155
8.
Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery.
Thromb Haemost
; 97(6): 1003-12, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17549304
9.
Anti-coxsackieviral efficacy of RNA interference is highly dependent on genomic target selection and emergence of escape mutants.
Oligonucleotides
; 17(1): 44-53, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17461762
10.
Vascular remodeling in mice lacking the cytoplasmic domain of tissue factor.
Circ Res
; 97(3): 293-8, 2005 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-16020755
11.
Limus is not limus--a proposal to adjust terminology in the context of drug-eluting stents.
J Cardiovasc Pharmacol
; 59(5): 485-6, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22441300
12.
Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis.
PLoS One
; 12(6): e0180029, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28644868
13.
Clinical outcomes with the STENTYS self-apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction: two-year insights from the APPOSITION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry.
EuroIntervention
; 13(5): e572-e577, 2017 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28191875
14.
One-Year Clinical Outcomes of Patients Presenting With ST-Segment Elevation Myocardial Infarction Caused by Bifurcation Culprit Lesions Treated With the Stentys Self-Apposing Coronary Stent: Results From the APPOSITION III Study.
J Invasive Cardiol
; 29(8): 253-258, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28756418
15.
Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible mice.
Circulation
; 111(13): 1583-92, 2005 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-15795330
16.
Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating.
Arterioscler Thromb Vasc Biol
; 25(4): 748-53, 2005 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15681298
17.
Interference by interferons: Janus faces in vascular proliferative diseases.
Cardiovasc Res
; 66(3): 433-43, 2005 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15914108
18.
Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform.
Cardiovasc Res
; 68(3): 483-92, 2005 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16111664
19.
Economic impact of contrast-induced acute kidney injury associated with invasive cardiology: role of iso-osmolar contrast media in Germany, Italy, Poland, and Spain.
J Med Econ
; 19(2): 158-68, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26451530
20.
Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
FASEB J
; 18(11): 1285-7, 2004 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15180955